Microfluidics
Managers
Benjamin Péant
PhD
Amélie St-Georges-Robillard
PhD
Microfluidic devices (also called lab-on-a-chip devices) offer excellent spatial-temporal control over biological samples and their microenvironments.
The devices preserve the viability and architecture of tissue samples under appropriate culture conditions. In oncology, the microfluidics approach can be used to observe the effects of chemotherapy and radiation therapy treatments on solid tumour and biopsy samples.
Benjamin Péant
PhD
Co-Manager
Amélie St-Georges-Robillard
PhD
Co-Manager
Jennifer Kendall-Dupont
MSc
Specialist
Anne-Marie Mes-Masson
PhD, FCAHS, FRSC
Scientific Co-Advisor
Thomas Gervais
PhD, Eng
Scientific Co-Advisor
In figures
-
>than 50,000 microtumours produced in 2 years
> than 1,500 microfluidic devices, each loaded with 32 microtumours
about 40 people trained in 2 years
In images
© CHUM